Cost-Effectiveness and Clinical Outcomes of Controlled Ovarian Stimulation With Follitropin Delta and Follitropin Alfa: A Retrospective Study
Using Follitropin Delta for controlled ovarian stimulation in ART may be more cost-effective than Follitropin Alfa under Japan's Health Care Insurance System, offering higher cumulative live birth rates and minimal additional costs.
Authors
- Masato Kobanawa (ORCID: https://orcid.org/0000-0002-5545-0477)
- Kunihiro Enatsu
- Masachi Hanaoka (ORCID: https://orcid.org/0000-0003-0984-4595)
- Nanako Iwami (ORCID: https://orcid.org/0000-0001-7262-7791)
- Takuhiko Ichiyama (ORCID: https://orcid.org/0000-0003-0641-934X)
Institutions
- Mukogawa Women's University (JP)
- Ladies College (LK)
- Kobatake Hospital (JP)
- Reproductive Medicine Institute (US)
- Institut de Médecine de la Reproduction (FR)
Publication Details
- Journal
- Cureus
- Published
- 2024-12-25
- DOI
- https://doi.org/10.7759/cureus.76371
- Citations
- 4
- Primary Topic
- Ovarian function and disorders
- Type
- article
- Field-Weighted Citation Impact
- 2.15